Monte Rosa Therapeutics宣布Mrt-2359与恩扎卢胺联合使用在重度预处理的转移性去势抵抗性前列腺癌患者中展现出显著的临床活性

美股速递
Dec 16, 2025

Monte Rosa Therapeutics宣布Mrt-2359与恩扎卢胺联合使用在重度预处理的转移性去势抵抗性前列腺癌患者中展现出显著的临床活性。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10